Skip to main content
Premium Trial:

Request an Annual Quote

Visible Genetics Gets Patent for Sequencer


TORONTO--Visible Genetics, manufacturer of automated DNA sequencing systems, has received a patent titled ``Virtual DNA Sequencer'' describing an interactive system capable of extremely high sequencing throughput.

The company said its technology is created by networking many independent, high-speed, automated DNA sequencers to a single computer to create what functions as a single large sequencer. The concept is similar to massively parallel computers used in the current generation of supercomputers.

By distributing the sequencing load over many smaller high-speed sequencers operating in parallel, workflow can be optimized, reliability is enhanced, and the end user has maximum flexibility.

"Eight Clipper units, our current automated DNA sequencer, combined into a single virtual instrument can sequence over 50,000 DNA bases per hour,'' said John Stevens, CEO.

"The performance advantages offered by a virtual sequencing network have the potential to provide our customers with optimal throughput and workflow flexibility, both critical features for generating rapid results in diagnostic applications.''

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.